ArthNow Logo
ArthNow
•2 min read•
✦Reported by cnbctv18

Fortis Healthcare shares in focus after revenue, EBITDA rise in Q2 - A look at how its business segments fared

Fortis Healthcare shares in focus after revenue, EBITDA rise in Q2 - A look at how its business segments fared
Source: cnbctv18

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Fortis Healthcare shares are in focus on Friday, November 6, after the company reported its second quarter results.
  • ✓Revenue grew 17.3% to ₹2,734.83 crore, while EBITDA rose 12% to ₹623.19 crore.
  • ✓However, net profit fell 3% to ₹312.38 crore.

Story at a Glance

Category
MARKET
Reported By
cnbctv18
Reading Speed
2 Minute(s)
Market Focus
India Economy

Fortis Healthcare's earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 12% to ₹623.19 crore from ₹556.33 crore in the prior fiscal. However, margins saw some contraction from last year.

Shares of Fortis Healthcare Ltd. are in focus on Friday, November 6, after the company reported its second quarter results after market hours on Thursday.

Net profit for the quarter witnessed a 3% decline during the quarter to ₹312.38 crore from ₹321.96 crore last year.

Revenue for Fortis Healthcare stood at ₹2,734.83 crore, a growth of 17.3% from the ₹2,331.44 crore that it reported in the September quarter last year.

Fortis Healthcare's earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 12% to ₹623.19 crore from ₹556.33 crore in the prior fiscal.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

cnbctv18

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article
Fortis Healthcare shares in focus after revenue, EBITDA rise in Q2 - A look at how its business segments fared | ArthNow